Furthermore, CYT-Rx20 treatment had an inhibitory effect on cancer cell migration and invasion through activation of epithelial maker (ZO-1) and inactivation of mesenchymal markers (N-cadherin, ZEB1, Slug, Snail) (Fig 2C). This evidence concerns the gene ZEB1 and cancer.